To investigate the downstream effectors of GSK-3β-mediated inhibition of let-7, we focused on evidence that silencing GSK-3β triggered cell death and elevated p53 expression in colon cancer cells [45]. This evidence concerns the gene TP53 and malignant colon neoplasm.